Brochure: Albumin Fusion Technology
Source: Novozymes Biopharma US Inc.
albufuse™, albumin fusion technology is the molecular fusion of albumin to protein drug candidates for improved half-life and bioavailability.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more